Form D · Pharmaceuticals
Icon Bioscience, Inc.
Sunnyvale, CA · CIK 0001401912
Offering snapshot reported Dec 3, 2015 · SEC filing
- Reported sold
- $5.32M Offering amount: $9.82M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 19, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 3, 2015 | Initial | $5,316,245 | No comparison | 18 | SEC filing |
| Aug 28, 2013 | Initial | $14,906,669 | No comparison | 8 | SEC filing |
| May 29, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-252351
Convertible Notes
Source: Form D, filed Dec 3, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joyce Erony | Director |
| Michael Hemric | Director |
| David Tierney | Director, Executive |
| Song Tjoa | Director |
| Song Toja | Director |
| William White | Director |
| Vernon Wong | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1253 Reamwood Avenue
Sunnyvale, CA, 94089
Sunnyvale, CA, 94089